Literature DB >> 29547609

Chronic Obstructive Pulmonary Disease: Clinical Implications for Patients With Lung Cancer

Brandi R Newsome1, Karen McDonnell1, Jennifer Hucks1, Robin Dawson Estrada1.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is the most common smoking-related illness. COPD often is underemphasized as a comorbidity except when considering issues surrounding surgical treatment options.
OBJECTIVES: This article aims to provide nurses with an overview of the pharmacologic and nonpharmacologic treatment implications of COPD.
METHODS: Definitions, differentials, and treatment considerations are provided, and clinical implications and resources are described.
FINDINGS: The added burden of dyspnea, fatigue, and psychological distress related to COPD may affect the overall outcome and quality of life (QOL) of patients with lung cancer. Attention to the prevention, assessment, and treatment of lung cancer and COPD and related symptomatology will help maximize patients' QOL.

Entities:  

Keywords:  chronic obstructive pulmonary disease; immunotherapy; lung cancer; quality of life

Mesh:

Year:  2018        PMID: 29547609      PMCID: PMC6613547          DOI: 10.1188/18.CJON.184-192

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  2 in total

Review 1.  Mindfulness-Based Symptom and Stress Management Apps for Adults With Chronic Lung Disease: Systematic Search in App Stores.

Authors:  Otis L Owens; Jenay M Beer; Ligia I Reyes; David G Gallerani; Amanda R Myhren-Bennett; Karen K McDonnell
Journal:  JMIR Mhealth Uhealth       Date:  2018-05-15       Impact factor: 4.773

2.  A Prospective Pilot Study Evaluating Feasibility and Preliminary Effects of Breathe Easier: A Mindfulness-based Intervention for Survivors of Lung Cancer and Their Family Members (Dyads).

Authors:  Karen Kane McDonnell; David G Gallerani; Brandi R Newsome; Otis L Owens; Jenay Beer; Amanda R Myren-Bennett; Elizabeth Regan; James W Hardin; Lisa A Webb
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.